What is the difference between Herpes Simplex Virus type 1 (HSV-1) and Herpes Simplex Virus type 2 (HSV-2)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

HSV1 and HSV2 are two distinct types of herpes simplex viruses that primarily differ in their preferred infection sites, transmission methods, and recurrence rates, with HSV1 mainly causing oral herpes and HSV2 causing genital herpes, as noted in the 2022 study by Christine Johnston et al. 1. The main differences between HSV1 and HSV2 lie in their preferred sites of infection and modes of transmission.

  • HSV1 typically causes oral herpes, manifesting as cold sores around the mouth and lips, and is mainly transmitted through oral contact like kissing or sharing utensils.
  • HSV2, on the other hand, generally causes genital herpes and is primarily spread through sexual contact. Both viruses establish lifelong infections by remaining dormant in nerve cells between outbreaks, and both can infect either location, although HSV1 prefers the oral region and HSV2 the genital area. The symptoms and appearance of sores from both viruses are similar, and both are treated with the same antiviral medications like acyclovir, valacyclovir, or famciclovir, as discussed in the 2022 study 1. However, the recurrence rates and transmission risks differ significantly between HSV1 and HSV2, with HSV2 having a higher recurrence rate and transmission risk, particularly during asymptomatic periods, as highlighted in the 1998 guidelines for treatment of sexually transmitted diseases 1. It is essential to distinguish between these viruses to understand transmission risks and implement appropriate preventive measures, especially considering that genital HSV1 infection is associated with less shedding and fewer recurrences compared to HSV2, as noted in the 2022 study by Christine Johnston et al. 1. In terms of management, the recommended approaches differ based on the viral type (HSV-1 vs HSV-2) and the presence and absence of symptoms, with episodic therapy recommended for recurrences and suppressive therapy considered for reducing transmission risk, as discussed in the 2022 study 1. Overall, understanding the differences between HSV1 and HSV2 is crucial for effective management and prevention of transmission, and healthcare providers should prioritize counseling messages that differ for those with genital HSV-1 vs HSV-2 infection, taking into account the decreased risk of shedding and transmission associated with HSV1, as highlighted in the 2022 study 1.

From the Research

Difference between HSV1 and HSV2

  • HSV1 and HSV2 are two types of herpes simplex virus, with different primary infection sites and recurrence rates 2.
  • HSV1 is primarily associated with oral herpes, while HSV2 is primarily associated with genital herpes 3.
  • Both types of HSV can cause similar symptoms, including painful blisters or sores, but the location and frequency of outbreaks can vary 4.
  • Antiviral medications such as acyclovir, valacyclovir, and famciclovir are effective against both HSV1 and HSV2, but resistance to these medications can occur, particularly in immunocompromised patients 5, 6.
  • The mechanisms of resistance to antiviral drugs differ between HSV1 and HSV2, with mutations in the thymidine kinase (TK) gene being more common in HSV2 6.
  • Treatment options for resistant HSV infections include foscarnet and cidofovir, which can be effective against both HSV1 and HSV2, but may have more toxic side effects than other antiviral medications 3, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Recent developments in herpesvirus therapy.

Herpes : the journal of the IHMF, 2001

Research

Herpes simplex virus resistance to antiviral drugs.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.